Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation Patients
Links shared publicly online about this topic.
- 0total visits
Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation Patients
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Arrhythmia, Atrial Fibrillation, Drug, FDA, Anti-Clotting Medication, Xarelto
Most Recently Shared on November 4, 2011 at 8:05 pm By:
Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation Patients http://t.co/I5BSybmw #heart #heartdisease
Also Shared By:
Letter to FDA Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial Fibrillation
citizen.org — “Letter to FDA Opposing Approval of Rivaroxaban (Xarelto) for Anticoagulation Therapy in Patients With Atrial Fibrillation” View full resource at citizen.org
Most Recently Shared on November 8, 2011 at 6:19 pm By:
Sidney Wolfe, MD Internist, Physician, and Doctor
@US_FDA ignores @Public_Citizen and expands Xarelto use to prevent strokes. See the letter we sent to the FDA. http://t.co/Qctgd29G
FDA Okays Xarelto for Stroke Prevention - ABC News
abcnews.go.com — “The FDA has approved rivaroxaban (Xarelto) for prevention of stroke in patients with nonvalvular atrial fibrillation.” View full resource at abcnews.go.com
Most Recently Shared on November 4, 2011 at 8:11 pm By:
Tom Heston, MD Physician, Doctor, and Family Medicine Doctor
FDA Okays Xarelto for Stroke Prevention - ABC News http://t.co/u3b73w1x #health
Medical News: Public Citizen Calls on FDA to Nix Xarelto - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “The consumer group Public Citizen has asked the FDA not to approve rivaroxaban (Xarelto) for use in patients with atrial fibrillation because of safety and efficacy concerns.” View full resource at medpagetoday.com
Most Recently Shared on October 21, 2011 at 5:08 pm By:
Public Citizen calls on FDA to nix Xarelto: http://t.co/rwTVn8uf
Bayer, J&J Blood Thinner Gets FDA Panel Backing For New Indication
rttnews.com — “Blood thinner Xarelto, co-developed by Bayer HealthCare, a subsidiary of German chemical and pharmaceutical giant Bayer AG (BYR.L) (BAYRY.PK) and Johnson & Johnson (JNJ) won an FDA expert panel vote Thursday, backing the approval of the drug for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in the U.” View full resource at rttnews.com
Most Recently Shared on September 9, 2011 at 12:28 pm By:
Drugs and Devices OW OW Health
Bayer, J&J Stroke Drug Gets FDA Panel Backing - RTT News: USA TodayBayer, J&J Stroke Drug Gets FDA Panel B... http://t.co/ruIUBoN #drug
Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban
news-medical.net — “Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.” View full resource at news-medical.net
Most Recently Shared on September 9, 2011 at 8:24 am By:
News-Medical.Net Health News and Oncology
Oncology News: Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban... http://t.co/X1iH6Uy
Xarelto (Rivaroxaban) Recommended For Patients With Non-valvular Atrial Fibrillation, USA - QualityPoint Technologies
qualitypointtech.net — “Anticoagulant Xarelto (rivaroxaban) has been recommended by the FDA's Cardiovascular Renal Drugs Advisory Committee for the prevention of systemic embolism and stroke in patients with non-valvular AF (atrial fibrillation). The Committee, also known as the Panel, voted 9 to 2 in favour, with 1 abstention. The FDA (Food and Drug Administration) is expected to make a final decision on September 8th. The Panel's verdict is not binding; the FDA can ignore the recommendation if it so wishes. However, ” View full resource at qualitypointtech.net
Most Recently Shared on September 9, 2011 at 4:45 am By:
Xarelto (Rivaroxaban) Recommended For Patients With Non-valvular Atrial Fibrillation, USA: Anticoagulant Xarelto (... http://t.co/gCEPMUn
Xarelto (Rivaroxaban) Recommended For Patients With Non-valvular Atrial Fibrillation, USA
medicalnewstoday.com — “Anticoagulant Xarelto (rivaroxaban) has been recommended by the FDA's Cardiovascular Renal Drugs Advisory Committee for the prevention of systemic embolism and stroke in patients with non-valvular” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2011 at 3:05 am By:
MNT Drug Approvals Health News
Xarelto (Rivaroxaban) Recommended For Patients With Non-valvular Atrial Fibrillation, USA http://mnt.to/3Zxg #regulatory
Panel Endorses Xarelto for Stroke Prevention - QualityPoint Technologies
qualitypointtech.net — “ADELPHI, Md. (MedPage Today) -- An FDA advisory committee has voted 9-2, with one abstention, to recommend that the FDA approve the direct oral factor Xa inhibitor rivaroxaban (Xarelto) to prevent stroke in patients with nonvalvular atrial fibrillation.” View full resource at qualitypointtech.net
Most Recently Shared on September 8, 2011 at 11:45 pm By:
Panel Endorses Xarelto for Stroke Prevention: ADELPHI, Md. (MedPage Today) -- An FDA advisory committee has voted ... http://t.co/LirKpWx
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA reviewer.” View full resource at qualitypointtech.net
Most Recently Shared on September 6, 2011 at 5:00 pm By:
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib: WASHINGTON (MedPage Today) -- Rivaroxaban (Xarelto) is ... http://t.co/6bEwbRZ
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:51 pm By:
HealthTrendster Health Executive
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib: WASHINGTON (MedPage Today… http://t.co/knMi5wv
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:49 pm By:
Patricia Grace Eldercare Expert
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib: WASHINGTON (MedPage Today) -- Rivaroxaban (Xarelto) i... http://t.co/U0jTyUN
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:11 pm By:
FDA reviewer slams Xarelto for stroke prevention in Afib: http://t.co/d4nW7Qp
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:10 pm By:
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib http://t.co/NJ3BLJN
Advertisement
MNT Drug Approvals
@mnt_drugapprov
Xarelto (Rivaroxaban) Recommended For Patients With Non-valvular Atrial Fibrillation, USA http://mnt.to/3Zxg #regulatory
1 year ago...